Core Viewpoint - Baiyang Pharmaceutical (301015.SZ) has not yet entered the GLP-1 weight loss product market, despite clinical evidence showing that over 30% of patients experience significant weight loss while using GLP-1 drugs, which can lead to muscle loss [1] Group 1: Company Positioning - The company emphasizes that oral whey protein is currently recognized as one of the best nutritional interventions for patients experiencing weight loss due to GLP-1 medications [1] - Baiyang Pharmaceutical's own brand, NutriShuma, has maintained its position as the top-selling imported pure whey protein powder in China [1] Group 2: Market Insights - The clinical data indicates that more than 30% of patients using GLP-1 drugs show significant weight loss, highlighting a potential market for nutritional support products [1]